Thomas Nothnagl

420 total citations
17 papers, 315 citations indexed

About

Thomas Nothnagl is a scholar working on Rheumatology, Infectious Diseases and Genetics. According to data from OpenAlex, Thomas Nothnagl has authored 17 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 3 papers in Infectious Diseases and 2 papers in Genetics. Recurrent topics in Thomas Nothnagl's work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Thomas Nothnagl is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (5 papers) and Spondyloarthritis Studies and Treatments (4 papers). Thomas Nothnagl collaborates with scholars based in Austria and United States. Thomas Nothnagl's co-authors include Burkhard F. Leeb, B. Rintelen, Judith Sautner, H P Brezinschek, Péter Mandl, Daniel Mrak, Helga Radner, Stefan Winkler, Daniel Aletaha and Heinz Burgmann and has published in prestigious journals such as Annals of the Rheumatic Diseases, BMC Musculoskeletal Disorders and Drugs & Aging.

In The Last Decade

Thomas Nothnagl

16 papers receiving 293 citations

Peers

Thomas Nothnagl

RHEUM

HEMAT

IMMUN

PFM

C Balakrishnan India

Claudia Elera‐Fitzcarrald Peru

K. Ben Abdelghani Tunisia

Leonor Barile Mexico

Marie Couret France

Anke Liebhaber Germany

Jozélia Rêgo Brazil

Kirsten Karberg Germany

I Valls France

L. Sparsa France

C Balakrishnan India

Thomas Nothnagl

146 ×0.6

RHEUM

54 ×0.5

HEMAT

71 ×1.4

IMMUN

45 ×0.9

PFM

21 ×0.7

Citations per year, relative to Thomas Nothnagl Thomas Nothnagl (= 1×) peers C Balakrishnan

Countries citing papers authored by Thomas Nothnagl

Since Specialization

Citations

This map shows the geographic impact of Thomas Nothnagl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Nothnagl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Nothnagl more than expected).

Fields of papers citing papers by Thomas Nothnagl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Nothnagl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Nothnagl. The network helps show where Thomas Nothnagl may publish in the future.

Co-authorship network of co-authors of Thomas Nothnagl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Nothnagl. A scholar is included among the top collaborators of Thomas Nothnagl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Nothnagl. Thomas Nothnagl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tobudic, Selma, Elisabeth Simader, Felix Kartnig, et al.. (2023). The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination. Frontiers in Medicine. 10. 1049157–1049157. 5 indexed citations

Mandl, Péter, Selma Tobudic, Thomas Karonitsch, et al.. (2022). Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study. Annals of the Rheumatic Diseases. 81(7). 1017–1022. 12 indexed citations

Simader, Elisabeth, Selma Tobudic, Péter Mandl, et al.. (2021). Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis. Annals of the Rheumatic Diseases. 81(3). 416–421. 17 indexed citations

Bröll, H, et al.. (2018). The Efficacy and Safety of Tocilizumab in the Treatment of Rheumatoid Arthritis: An Austrian Non-Interventional Study. 2(1).

Puchner, Rudolf, H.-P. Brezinschek, Josef Fritz, et al.. (2015). Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a survey. BMC Musculoskeletal Disorders. 16(1). 109–109. 2 indexed citations

Duftner, Christina, Christian Dejaco, F. Kainberger, et al.. (2014). Empfehlungen der Österreichische Gesellschaft für Rheumatologie und Rehabilitation/Austrian Radiology-Rheumatology Initiative for Musculoskeletal Ultrasound zur Anwendung des Ultraschalls bei rheumatischen Erkrankungen in der klinischen Praxis. Wiener klinische Wochenschrift. 126(23-24). 809–814. 1 indexed citations

Puchner, Rudolf, H.-P. Brezinschek, Manfred Herold, et al.. (2014). Quality of care of rural rheumatoid arthritis patients in Austria. Wiener klinische Wochenschrift. 126(11-12). 360–367. 5 indexed citations

Leeb, Burkhard F., et al.. (2014). RADAI-5 to monitor rheumatoid arthritis.. PubMed. 32(5 Suppl 85). S–55. 16 indexed citations

Duftner, Christina, Péter Mandl, Thomas Nothnagl, et al.. (2013). Clinical implementation of musculoskeletal ultrasound in rheumatology in Austria. Rheumatology International. 34(8). 1111–1115. 6 indexed citations

10.

Rintelen, B., H.-P. Brezinschek, Gérard Eberl, et al.. (2010). Österreichische Empfehlungen zum Gebrauch von Methotrexat in der Rheumatologie – Expertenkonsensus basierend auf einer systematischen Literatursuche. Aktuelle Rheumatologie. 35(4). 251–259. 2 indexed citations

11.

Rintelen, B., et al.. (2008). SDAI/CDAI levels in rheumatoid arthritis patients are highly dependent on patient's pain perception and gender. Scandinavian Journal of Rheumatology. 37(6). 410–413. 16 indexed citations

12.

Leeb, Burkhard F., et al.. (2008). Patient-centered rheumatoid arthritis disease activity assessment by a modified RADAI.. PubMed. 35(7). 1294–9. 63 indexed citations

13.

Leeb, Burkhard F., et al.. (2007). The Disease Activity Score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients. Arthritis Care & Research. 57(2). 256–260. 34 indexed citations

14.

Leeb, Burkhard F., et al.. (2007). Disease activity score-28 values differ considerably depending on patient's pain perception and sex.. PubMed. 34(12). 2382–7. 67 indexed citations

15.

Nothnagl, Thomas & Burkhard F. Leeb. (2006). Diagnosis, Differential Diagnosis and Treatment of Polymyalgia Rheumatica. Drugs & Aging. 23(5). 391–402. 15 indexed citations

16.

Leeb, Burkhard F., et al.. (2005). Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis Care & Research. 53(1). 56–60. 53 indexed citations

17.

Nothnagl, Thomas, et al.. (2004). Polymyalgia rheumatica - ein klinischer Überblick. Journal für Kardiologie (Krause & Pachernegg GmbH). 11(1). 37–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact